Collection of genetic material and data for future research
Official title: Biobank Clinical Genetics Maastricht
Run by Maastricht University Medical Center · NCT02266615 · Data updated 2026-11-12
This study is collecting genetic samples and health information from new patients to help researchers learn more about genetic diseases and find new treatments.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 3600 (estimated) |
| Sponsor | Maastricht University Medical Center Academic / other |
| Locations | 1 site (Maastricht, Limburg) |
| Status | Recruiting |
| Started | September 2014 |
| Main results expected | March 2024 |
| Study ends | January 2035 |
| Registry record updated | October 6, 2025 |
| Trial ID | NCT02266615 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are new patients visiting the Clinical Genetics outpatient clinic who are willing to provide body material for genetic diagnostics.
✕Probably not a fit
Patients who do not understand the Dutch language may not benefit from this study due to communication barriers.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study involves the collection of coded biomaterial and clinical data from new patients visiting the outpatient clinic of the Clinical Genetics department at Maastricht University Medical Center. Participants provide consent for their samples to be used in future research aimed at identifying new gene mutations and potential treatment options. The study focuses on genetic diseases and aims to enhance understanding of genetic conditions through biobanking efforts.
Why it matters
Potential benefit: If successful, this research could lead to the identification of new genetic mutations and improved treatment options for patients with genetic diseases.
How similar studies have gone: Other studies involving biobanking and genetic research have shown success in identifying genetic mutations and advancing treatment options, indicating that this approach is promising.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * New patients visiting the out patient clinic of the department of Clinical Genetics of the Maastricht University Medical Hospital * Withdrawal of body material for genetic diagnostics. Exclusion Criteria: * Patient does not understand the Dutch language.
Where it's running
-
Maastricht University Medical Center
Maastricht, Limburg, Netherlands Recruiting
Study contacts
- Study coordinator: I. Krapels, MD, PhD
- Email: ingrid.krapels@mumc.nl
- Phone: +31433875880
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Newborn whole-genome sequencing and genetic disease risk in pregnancy and early life
This project will collect small biological samples from pregnant families and newborns to try whole-genome sequencing and other multi-omics tests to find genetic disease risks.
-
Multicenter study of SHANK3-related Phelan-McDermid syndrome genetic modifiers
Researchers are testing how other genes may modify the PMS clinical picture in people with SHANK3-related deletions or variants.
-
Prenatal cfDNA Screening in Pregnancies with Diverse Genetic Risk Profiles
This study tests two cfDNA approaches from a single maternal blood sample to see if they can detect a wide range of fetal genetic conditions in pregnant people with various risk factors.
-
Natural history of type I interferonopathies in a European patient group
This project will follow people with genetically confirmed type I interferonopathies across European centers to see how the disease develops and which clinical and blood markers track disease activity.
-
Speech-generating device to help communication in childhood dementia
This project will test whether giving children with childhood dementia a speech-generating iPad app helps them communicate better than their usual care.
-
Using AI to enhance cardiology patient care
This study is testing if using AI tools can help cardiologists make better decisions when treating patients with heart conditions compared to traditional methods.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.